杭州启明医疗器械股份有限公司 VENUS MEDTECH (HANGZHOU) INC.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Venus Medtech Acquires U.S. Company InterValve to Create a Systematic TAVR Treatment and Strengthen Global Expansion 2017-06-14 22:21
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China 2017-04-28 21:45
The Successful Worldwide First in Human Implantation of an Innovative Aortic Valve from Colibri Heart Valve and Venus Medtech with Disruptive "Dry Tissue" Technology Conducted 2016-10-28 10:42
Venus Medtech's Transcatheter Pulmonary Valve Debuts in Europe, Marking the Start of Global Clinical Trial 2016-09-19 13:18
First Ever Venus P-Valve Implantations in Latin America 2016-04-06 21:10
Venus Medtech Receives Investment from Goldman Sachs, and Establishes Cardiac Valve Research Institute Together with the Second Affiliated Hospital of Zhejiang University 2016-03-25 15:03
1 2